SCM Pharma appoints Adam Sims
pharmafile | July 5, 2011 | Appointment | Manufacturing and Production, Research and Development | appointment, manufacturing and production, research and development
Sterile filling specialist SCM Pharma has bolstered its senior management team with the appointment of Adams Sims as a non-executive director.
He joins the UK-based contract manufacturing organisation (CMO) with a 20-year track record in the global pharmaceutical and chemical sector.
Prior to joining SCM Adam spent seven years at Aesica in senior commercial and finance roles
He said: “I am looking forward to supporting the executive team with my industry contacts, experience and knowledge to help ensure it continues to maintain its high profile, thrive as an independent business and achieve its commercial objectives.”
The CMO recently picked up a major commercial supply project with Speciality European Pharma (SEP) for its oncology product Plenaxis and a sterile filling project from Italian firm Molteni Therapeutics for a phase II clinical trial.
Related Content

PlasmidFactory founder Dr. Martin Schleef honoured with the NRW Innovation Award 2025
The founder and long-standing CEO of PlasmidFactory, Dr. Martin Schleef, was honoured in Düsseldorf with …

Rotzinger launches modular filling and capping platform for over-the-counter products
Rotzinger PharmaPack has launched a new filling and capping platform called VarioFill, designed to handle …

AAX Biotech announces collaboration for cardiovascular antibody therapy
Swedish biotech firm AAX Biotech has entered a new collaboration focused on the development of …






